Forma Therapeutics (FMTX) News Today → New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad) Free FMTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinemarketbeat.com - October 14 at 6:00 AMForma Therapeutics Holdings, Inc. (NASDAQ:FMTX) Receives Average Rating of "Hold" from Brokeragesmarketbeat.com - September 27 at 4:13 AMForma Therapeutics Holdings, Inc. (FMTX)finance.yahoo.com - September 25 at 7:48 AMBiotech Stock Roundup: GILD's Updates, FMTX Up on NVO Deal, SPRO Surges & Morefinance.yahoo.com - September 7 at 3:23 PMSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates GMTX, FMTX, SGFY, ECOMapnews.com - September 7 at 10:22 AMThe M&A Class Action Firm Announces the Investigation of Forma Therapeutics Holdings, Inc. - FMTXbenzinga.com - September 7 at 12:22 AM4 Analysts Have This to Say About Forma Therapeutics Hldgsmarkets.businessinsider.com - September 2 at 3:19 PMForma Therapeutics Holdings, Inc. (NASDAQ:FMTX) Given Average Rating of "Hold" by Brokeragesmarketbeat.com - September 2 at 8:30 AMForma Therapeutics (NASDAQ:FMTX) Downgraded by HC Wainwrightmarketbeat.com - September 2 at 7:26 AMForma Therapeutics: Rare Disease Playseekingalpha.com - September 2 at 12:18 AMNovo Nordisk To Acquire Forma Therapeutics - Quick Factsmarkets.businessinsider.com - September 1 at 9:12 AMNovo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disordersfinance.yahoo.com - September 1 at 9:12 AMNovo Nordisk to Buy Forma Therapeutics for $1.1 Billion >FMTX NVOmarketwatch.com - September 1 at 9:12 AMFMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Forma Therapeutics, Holdings Inc. Is Fair to Shareholdersapnews.com - September 1 at 9:12 AMForma Therapeutics to be acquired by Novo Nordisk in a cash deal valued at $1.1 billionfinance.yahoo.com - September 1 at 9:12 AMUPDATE 1-Novo Nordisk to acquire Forma Therapeutics in $1.1. bln dealfinance.yahoo.com - September 1 at 9:12 AMmarketbeat.com - September 1 at 7:58 AMForma Therapeutics Holdings, Inc. (NASDAQ:FMTX) Short Interest Down 8.8% in Augustmarketbeat.com - August 31 at 6:58 AMForma Therapeutics Holdings, Inc. (NASDAQ:FMTX) up 28%, but insiders miss out having sold stock earlier this yearnasdaq.com - August 11 at 4:18 PMForma Therapeutics Holdings, Inc. (NASDAQ:FMTX) to Post FY2022 Earnings of ($4.19) Per Share, Cantor Fitzgerald Forecastsmarketbeat.com - August 10 at 11:25 AMForma Therapeutics (NASDAQ:FMTX) Price Target Cut to $33.00 by Analysts at Credit Suisse Groupmarketbeat.com - August 9 at 2:32 PMRigel Pharma Expands Blood Cancer Portfolio With Forma Therapeutics Licensing Pactmsn.com - August 3 at 8:46 AMRigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid Leukemiafinance.yahoo.com - August 2 at 5:37 PMForma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022finance.yahoo.com - July 29 at 10:46 AMForma Therapeutics Holdings, Inc. (NASDAQ:FMTX) Sees Significant Decline in Short Interestmarketbeat.com - July 17 at 9:16 AMForma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)finance.yahoo.com - July 12 at 11:36 AMHow Much Upside is Left in Forma Therapeutics Holdings, Inc. (FMTX)? Wall Street Analysts Think 379%finance.yahoo.com - July 8 at 5:11 PMForma Therapeutics Announces Appointment of New Executive Team Membersfinance.yahoo.com - June 30 at 8:50 AMCan Forma Therapeutics Holdings, Inc. (FMTX) Climb 536% to Reach the Level Wall Street Analysts Expect?finance.yahoo.com - June 22 at 3:30 PMBears are Losing Control Over Forma Therapeutics Holdings, Inc. (FMTX), Here's Why It's a 'Buy' Nowfinance.yahoo.com - June 15 at 2:12 PMCantor Fitzgerald Comments on Forma Therapeutics Holdings, Inc.'s FY2022 Earnings (NASDAQ:FMTX)marketbeat.com - June 15 at 6:21 AMRead Why Forma Therapeutics' Current Price Level Is 'Attractive Entry Point'finance.yahoo.com - June 13 at 10:16 PMForma Therapeutics Holdings, Inc. to Post FY2023 Earnings of ($3.47) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:FMTX)marketbeat.com - June 8 at 7:43 AMForma Therapeutics to Present at the Jefferies Healthcare Conferencefinance.yahoo.com - June 3 at 10:43 AMForma Therapeutics (NASDAQ:FMTX) Lifted to "Buy" at Zacks Investment Researchmarketbeat.com - May 30 at 11:33 PMForma Therapeutics Highlights Etavopivat Development Expansion and Introduces New Oncology Program from Research Pipeline at Inaugural Research and Development (R&D) Dayfinance.yahoo.com - May 26 at 10:07 AMForma Therapeutics Holdings, Inc. to Post FY2022 Earnings of ($4.86) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:FMTX)marketbeat.com - May 12 at 7:12 AMForma Therapeutics' (FMTX) Overweight Rating Reaffirmed at Cantor Fitzgeraldmarketbeat.com - May 12 at 5:42 AMCompanies Like Forma Therapeutics Holdings (NASDAQ:FMTX) Are In A Position To Invest In Growthfinance.yahoo.com - May 8 at 12:42 PMForma Therapeutics Holdings Inc. (FMTX) CEO Frank Lee on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 6 at 1:22 PMForma Therapeutics Holdings Tops Q1 EPS by 12cinvesting.com - May 6 at 8:22 AMForma Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - May 6 at 8:22 AMPreview: Forma Therapeutics Hldgs's Earningsbenzinga.com - May 5 at 3:32 PMForma Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on May 6, 2022finance.yahoo.com - April 29 at 7:36 AMForma Therapeutics: Q4 Earnings Insightsbenzinga.com - March 1 at 5:49 PMForma Therapeutics GAAP EPS of -$1.06 misses by $0.10seekingalpha.com - March 1 at 5:49 PMForma Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Updatefinance.yahoo.com - March 1 at 5:49 PMForma Therapeutics to Report Fourth Quarter and Year-end 2021 Financial Results and Provide Business Update on March 1, 2022finance.yahoo.com - February 23 at 9:43 AMForma Therapeutics to Present at 11th Annual SVB Leerink Healthcare Conferencefinance.yahoo.com - February 8 at 11:08 AMForma Therapeutics Elects Esteemed Clinician and Industry Veteran Arturo Molina, M.D., to Board of Directors and R&D Committeefinance.yahoo.com - January 13 at 7:28 AM Get Forma Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address You’re invited: Biggest crypto event of 2024 (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. FMTX Media Mentions By Week FMTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FMTX News Sentiment▼0.000.53▲Average Medical News Sentiment FMTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FMTX Articles This Week▼00▲FMTX Articles Average Week Get Forma Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RLAY News Today IMTX News Today RGNX News Today BCRX News Today CABA News Today KYTX News Today CRGX News Today SRRK News Today PRME News Today CGEM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FMTX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forma Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.